Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDC has received approval from the FDA for its abbreviated new drug application, Ciprofloxacin ophthalmic solution.
Subscribe to our email newsletter
FDC’s Ciprofloxacin Ophthalmic Solution is a broad spectrum antibiotic used for occular surface infections.
The company has recently received approval for Timolol maleate ophthalmic solution. Another abbreviated new drug application Ofloxacin ophthalmic solution is in the final stages of approval.